https://imedic.health/en/health/news/neonatal-parenteral-nutrition-fda-starter-supply-access iMedic en 2026-09-27 Neonatal Parenteral Nutrition: What Does FDA Action Mean? https://imedic.health/en/health/news/waist-size-heart-disease-risk-beyond-bmi iMedic en 2026-09-27 Waist Size and Heart Disease: What Can BMI Miss? https://imedic.health/en/health/news/postpartum-intrusive-thoughts-infant-harm-research iMedic en 2026-09-27 Postpartum Intrusive Thoughts: Do They Signal Danger? https://imedic.health/en/health/news/type-2-diabetes-heart-kidney-complications-ten-year-risk iMedic en 2026-09-27 Type 2 Diabetes: What Does a 55% Complication Risk Mean? https://imedic.health/en/health/news/nasal-pain-relief-children-emergency-care-injections iMedic en 2026-09-27 Nasal Pain Relief for Children: Can It Replace Injections? https://imedic.health/en/health/news/ctx310-cholesterol-gene-editing-one-year-durability-results iMedic en 2026-09-27 CTX310 Cholesterol Gene Editing: What Do One-Year Data Show? https://imedic.health/en/health/news/evinacumab-angptl3-inherited-high-cholesterol-treatment iMedic en 2026-09-27 Evinacumab: Who Benefits From ANGPTL3 Cholesterol Treatment? https://imedic.health/en/health/news/libre-duo-fda-authorization-continuous-glucose-ketone-monitoring iMedic en 2026-09-27 Libre Duo: How Can Glucose-Ketone Monitoring Help? https://imedic.health/en/health/news/fda-approved-drugs-china-manufacturing-quality-treatment-access iMedic en 2026-09-28 FDA-Approved Drugs: What Does China’s Growing Role Mean? https://imedic.health/en/health/news/alzheimers-agitation-auvelity-rexulti-caregiver-treatment iMedic en 2026-09-28 Alzheimer’s Agitation: What Can New Drug Options Offer? https://imedic.health/en/health/news/exam-stress-blood-sugar-medical-students iMedic en 2026-09-28 Exam Stress and Blood Sugar: What a Student Study Found https://imedic.health/en/health/news/alzheimers-drugs-family-treatment-benefits-risks iMedic en 2026-09-28 Alzheimer's Drugs: How Should Families Weigh Treatment? https://imedic.health/en/health/news/fda-master-protocols-shared-clinical-trials-drug-development iMedic en 2026-09-28 FDA Master Protocols: Can Shared Trials Speed New Drugs? https://imedic.health/en/health/news/pelacarsen-heart-trial-setback-lipoprotein-a-treatment iMedic en 2026-09-28 Pelacarsen Heart Trial: What Does the Lp(a) Setback Mean? https://imedic.health/en/health/news/cholesterol-drug-trials-biomarkers-heart-protection-evidence iMedic en 2026-09-28 Cholesterol Drug Trials: What Proves Heart Protection? https://imedic.health/en/health/news/stroke-aphasia-brain-aging-language-impairment iMedic en 2026-09-28 Stroke Aphasia: How Does Brain Aging Affect Language? https://imedic.health/en/health/news/aortic-stenosis-lipoprotein-a-pelacarsen-valve-trial iMedic en 2026-09-28 Aortic Stenosis: Can Lp(a) Treatment Slow Valve Narrowing? https://imedic.health/en/health/news/heart-medication-deprescribing-when-fewer-pills-help iMedic en 2026-09-28 Heart Medication Deprescribing: When Can Fewer Pills Help? https://imedic.health/en/health/news/beta-blockers-after-heart-attack-smart-decision-abyss-trials iMedic en 2026-09-29 Beta-Blockers After Heart Attack: Why Do Trials Disagree? https://imedic.health/en/health/news/early-drug-trials-first-dose-participant-safety iMedic en 2026-09-29 First-in-Human Drug Trials: How Is Risk Reduced? https://imedic.health/en/health/news/insomnia-stroke-risk-review-sleep-treatment iMedic en 2026-09-29 Insomnia and Stroke: What Does a 26% Higher Risk Mean? https://imedic.health/en/health/news/dilated-cardiomyopathy-remission-heart-medication-withdrawal iMedic en 2026-09-29 Heart Failure Remission: Can You Stop Your Medication? https://imedic.health/en/health/news/stroke-recovery-circadian-rhythms-brain-waste-clearance iMedic en 2026-09-29 Stroke Recovery: Can Body Clock Treatments Help? https://imedic.health/en/health/news/ketogenic-therapy-mental-illness-clinician-training-trial-evidence iMedic en 2026-09-29 Ketogenic Therapy for Mental Illness: What Do Trials Show? https://imedic.health/en/health/news/rentosertib-pulmonary-fibrosis-lung-function-trial-evidence iMedic en 2026-09-29 Rentosertib for Pulmonary Fibrosis: What Did Its Trial Show?